Clearance of JC polyomavirus from cerebrospinal fluid following treatment with interleukin‐2 and pembrolizumab in an individual with progressive multifocal leukoencephalopathy and no underlying immune deficiency syndrome. (13th October 2020) - Goereci, Y.; Schweitzer, F.; Wellstein, A.; Silling, S.; Borchmann, S.; von Tresckow, B.; Adams, O.; Martin, R.; Schlamann, M.; Schroeter, M.; Fink, G. R.; Wattjes, M. P.; et al.